Thomas Jefferson University Awarded NIH Grant to Study Fibrotic Skin Disease Caused by MRI Contrast Agents
Wednesday, October 24, 2012 - 10:02
in Health & Medicine
Researchers at the Jefferson Institute of Molecular Medicine were awarded almost $384,000 by the National Institutes of Health to investigate the mechanisms involved in the development of a serious and sometimes fatal disease, known as Nephrogenic Systemic Fibrosis, a rare skin disorder linked to Gadolinium-based contrast agents used in magnetic resonance (MRI and MRA) studies.